Health Topics — Metabolic & Cognitive
Blood Sugar, Energy Crashes, and the ECS Connection
For the person whose energy crashes after meals, who craves sugar constantly, or whose energy feels unpredictable throughout the day — what the research shows.
The energy that is there after breakfast and gone by eleven. The crash that arrives in the afternoon, reliable as anything. The craving for something sweet that follows a meal and won't be reasoned with. The feeling that your energy is managed by something outside your control — that you are at the mercy of a cycle you can't quite break.
This is blood sugar dysregulation — and it is more common, more biological, and more connected to the stress systems than most advice about it accounts for.
Blood sugar — glucose in the bloodstream — rises after eating and falls as cells absorb it for energy, with insulin as the primary signal directing that absorption. In a well-regulated system, this cycle is smooth: glucose rises moderately after meals, insulin responds proportionately, cells absorb glucose efficiently, blood glucose returns to a stable baseline, and energy remains relatively even across the day.
When this system is dysregulated — when cells become resistant to insulin's signal, or when cortisol from chronic stress keeps blood glucose elevated, or when the hormonal signals that govern the cycle become erratic — the result is the energy pattern many people recognize: spikes and crashes, persistent cravings for sugar and refined carbohydrates, energy that doesn't match the food being eaten. This is not a willpower problem. It is a hormonal signaling problem.
Cortisol is a direct contributor. It raises blood glucose by prompting the liver to release stored glucose — a mechanism designed to fuel the muscles during the fight-or-flight response. Under chronic stress, this glucose-raising signal is persistent. Blood glucose stays elevated more often than it should. Insulin is produced more continuously in response. Over time, cells downregulate their insulin sensitivity. The cycle that was designed to be acute becomes chronic.
Where the endocannabinoid system fits
The endocannabinoid system is present in the pancreas — specifically in the beta cells that produce insulin — and in the liver and adipose tissue where insulin sensitivity is most relevant. CB1 receptors in pancreatic beta cells influence insulin secretion. CB2 receptors in immune cells within the pancreas modulate the inflammatory environment that chronic metabolic stress can create there.
PPAR-γ receptors — which CBG activates in preclinical research — are directly involved in glucose and fat metabolism. PPAR-γ is the receptor targeted by a pharmaceutical class of drugs used for type 2 diabetes — the thiazolidinediones — which work by improving insulin sensitivity through this same pathway. CBG's preclinical PPAR-γ activity does not make it a diabetes medication. It establishes a mechanistic connection to a pathway that is genuinely relevant to glucose regulation. The distance between preclinical mechanism and clinical outcome is real and must be stated plainly.
CBD has been examined in preclinical models of diabetes and metabolic dysfunction. Some animal research has found CB1-related improvements in insulin sensitivity and markers of metabolic function. No human trial has established CBD as a glucose-regulating intervention. The mechanistic research is real. The human evidence is not there yet.
What this means in practice
We can't tell you that a CBG or CBD preparation will stabilize your blood sugar or resolve energy crashes. The research does not support that claim and we do not make it. What the research provides is a picture of the biological systems involved in glucose regulation — including the endocannabinoid system's role within them — so that if you are considering a whole-plant preparation in the context of the metabolic patterns described here, you have an honest context for that consideration.
The upstream connection — through cortisol and the stress response — remains the most honest framing. Addressing the chronic stress load that elevates cortisol and promotes glucose dysregulation is relevant to the metabolic picture in ways that the mechanisms of CBG and CBD connect to most directly.
A note on blood sugar and medical care
If you experience significant energy instability, persistent sugar cravings, or suspect blood sugar dysregulation is affecting your daily function, clinical assessment is appropriate. Blood glucose patterns are measurable, and the context a clinician can provide is more specific than any general research framing.
Nothing in this article constitutes guidance on managing blood sugar, diabetes, or pre-diabetic conditions.
Future articles in this pillar examine PPAR-γ and the cannabinoid-glucose connection in mechanistic detail, the ECS in energy regulation, and the cortisol-metabolism cascade that underlies these patterns. The research section is the place to start for the fuller picture.
Blood sugar crashes and persistent sugar cravings are biology — governed by hormonal signaling, cortisol, and the endocannabinoid system's role in metabolic regulation. The research on cannabinoids and glucose regulation is preclinical and mechanistically grounded. The human evidence is not yet there. We present both parts of that picture honestly, because the person trying to understand their own energy deserves accurate information about what the research shows and what it doesn't.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.